A detailed history of Ken Fisher (Fisher Asset Management, LLC) transactions in Dexcom Inc stock. As of the latest transaction made, Fisher Asset Management, LLC holds 856,124 shares of DXCM stock, worth $68.5 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
856,124
Previous 773,874 10.63%
Holding current value
$68.5 Million
Previous $87.7 Million 34.61%
% of portfolio
0.02%
Previous 0.04%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$64.0 - $116.06 $5.26 Million - $9.55 Million
82,250 Added 10.63%
856,124 $57.4 Million
Q2 2024

Aug 14, 2024

SELL
$110.31 - $140.45 $760,146 - $967,840
-6,891 Reduced 0.88%
773,874 $87.7 Million
Q1 2024

May 09, 2024

SELL
$114.22 - $140.1 $24 Million - $29.4 Million
-209,780 Reduced 21.18%
780,765 $108 Million
Q4 2023

Mar 05, 2024

SELL
$75.49 - $124.16 $73,527 - $120,931
-974 Reduced 0.1%
990,545 $123 Million
Q4 2023

Feb 06, 2024

SELL
$75.49 - $124.16 $1.52 Million - $2.5 Million
-20,103 Reduced 1.99%
991,519 $123 Million
Q3 2023

Nov 13, 2023

SELL
$86.06 - $137.93 $22.5 Million - $36 Million
-260,967 Reduced 20.51%
1,011,622 $94.4 Million
Q2 2023

Dec 12, 2023

BUY
$112.47 - $130.98 $29.3 Million - $34.1 Million
260,288 Added 25.73%
1,271,910 $163 Million
Q2 2023

Aug 08, 2023

SELL
$112.47 - $130.98 $6.11 Million - $7.11 Million
-54,313 Reduced 4.09%
1,272,589 $164 Million
Q1 2023

Dec 12, 2023

BUY
$104.0 - $122.92 $31.7 Million - $37.4 Million
304,421 Added 30.09%
1,316,043 $153 Million
Q1 2023

May 01, 2023

SELL
$104.0 - $122.92 $5.49 Million - $6.49 Million
-52,766 Reduced 3.82%
1,326,902 $154 Million
Q4 2022

Feb 03, 2023

SELL
$84.98 - $122.67 $4.56 Million - $6.58 Million
-53,672 Reduced 3.74%
1,379,668 $156 Million
Q3 2022

Nov 08, 2022

BUY
$76.35 - $94.18 $82 Million - $101 Million
1,074,492 Added 299.43%
1,433,340 $115 Million
Q2 2022

Aug 09, 2022

BUY
$67.99 - $132.89 $18 Million - $35.2 Million
264,944 Added 282.14%
358,848 $26.7 Million
Q1 2022

May 05, 2022

BUY
$94.08 - $130.2 $757,061 - $1.05 Million
8,047 Added 9.37%
93,904 $48 Million
Q4 2021

Feb 02, 2022

BUY
$129.87 - $162.82 $4.13 Million - $5.17 Million
31,774 Added 58.75%
85,857 $46.1 Million
Q3 2021

Oct 26, 2021

SELL
$106.71 - $143.18 $13,125 - $17,611
-123 Reduced 0.23%
54,083 $29.6 Million
Q2 2021

Jul 27, 2021

BUY
$80.99 - $107.93 $327,685 - $436,684
4,046 Added 8.07%
54,206 $23.1 Million
Q1 2021

Apr 27, 2021

BUY
$84.79 - $104.74 $105,817 - $130,715
1,248 Added 2.55%
50,160 $18 Million
Q4 2020

Jan 29, 2021

BUY
$78.0 - $104.5 $2.11 Million - $2.83 Million
27,034 Added 123.57%
48,912 $18.1 Million
Q3 2020

Nov 10, 2020

BUY
$95.51 - $112.95 $30,945 - $36,595
324 Added 1.5%
21,878 $9.02 Million
Q2 2020

Aug 07, 2020

BUY
$62.68 - $105.34 $1.35 Million - $2.27 Million
21,554 New
21,554 $8.74 Million

Others Institutions Holding DXCM

About DEXCOM INC


  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $30.9B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track Ken Fisher's Portfolio

Track Ken Fisher Portfolio

Follow Ken Fisher (Fisher Asset Management, LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fisher Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fisher Asset Management, LLC and Ken Fisher with notifications on news.